VTYXVentyx Biosciences, Inc.

Nasdaq ventyxbio.com


$ 4.47 $ 0.04 (0.9 %)    

Thursday, 09-May-2024 15:59:22 EDT
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 4.48
$ 4.44
$ 0.00 x 0
$ 0.00 x 0
$ 4.44 - $ 4.64
$ 1.87 - $ 40.58
555,102
na
277M
$ 0.44
$ 771.58
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-27-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-23-2023 12-31-2022 10-K
7 11-04-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-23-2022 12-31-2021 10-K
11 11-18-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ventyx-biosciences-q1-2024-gaap-eps-062-beats-067-estimate

Ventyx Biosciences (NASDAQ:VTYX) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(...

 kura-sushi-posts-upbeat-sales-joins-caribou-biosciences-krispy-kreme-and-other-big-stocks-moving-higher-in-fridays-pre-market-session

U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Friday.

 canaccord-genuity-maintains-buy-on-ventyx-biosciences-lowers-price-target-to-15

Canaccord Genuity analyst Edward Nash maintains Ventyx Biosciences (NASDAQ:VTYX) with a Buy and lowers the price target from...

 wells-fargo-upgrades-ventyx-biosciences-to-overweight-raises-price-target-to-16

Wells Fargo analyst Derek Archila upgrades Ventyx Biosciences (NASDAQ:VTYX) from Equal-Weight to Overweight and raises the p...

 oppenheimer-upgrades-ventyx-biosciences-to-outperform-announces-12-price-target

Oppenheimer analyst Jeff Jones upgrades Ventyx Biosciences (NASDAQ:VTYX) from Perform to Outperform and announces $12 price ...

 dow-turns-higher-gds-holdings-shares-climb

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning higher on Monday. The Dow traded up 0.08%...

 why-mesoblast-shares-are-trading-higher-by-13-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an ...

 canaccord-genuity-maintains-buy-on-ventyx-biosciences-lowers-price-target-to-16

Canaccord Genuity analyst Edward Nash maintains Ventyx Biosciences (NASDAQ:VTYX) with a Buy and lowers the price target from...

 crude-oil-edges-higher-lexicon-pharmaceuticals-shares-jump

U.S. stocks traded lower midway through trading, with the Dow Jones index dipping over 50 points on Monday. The Dow traded dow...

 whats-going-on-with-autoimmuneinflammatory-disorder-focused-ventyx-biosciences-on-monday

Ventyx Biosciences provides clinical and pipeline updates, revealing compelling results in NLRP3 inhibitor development. CEO Raj...

 eqt-genie-energy-and-other-big-stocks-moving-lower-on-monday

U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.

 ventyx-biosciences-will-provide-clinical-and-pipeline-updates-during-its-virtual-investor-event

VTX3232 was well-tolerated in the Phase 1 trial with robust target coverage achieved in both plasma and CSF; Ventyx is planni...

 smith--wesson-brands-reports-upbeat-earnings-joins-americas-car-mart-hci-group-and-other-big-stocks-moving-higher-on-friday

U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Friday.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION